Form 4: CVS Health SVP, Controller & Chief Accounting Officer, James David Clark, Reports Share Transaction
SEC Form 4 Filing
James David Clark, SVP, Controller & Chief Accounting Officer at CVS Health, reported a transaction involving the withholding of shares to cover FICA taxes.
Summary
- James David Clark, a Senior Vice President, Controller, and Chief Accounting Officer at CVS Health, filed a Form 4.
- The filing reports a transaction on November 30, 2024, where 86 shares of common stock were withheld by CVS Health to cover FICA taxes due to Mr. Clark's retirement eligibility.
- Following this transaction, Mr. Clark directly owns 8,394 shares of common stock and 15,109 restricted shares.
- The filing also details Mr. Clark's holdings of various stock options with different exercise prices and expiration dates, totaling 86,459 shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing an insider transaction. It does not indicate any positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the holdings of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for all publicly traded companies in the US, as mandated by the SEC.
- The details of the stock options and their vesting schedules are typical for executive compensation packages in large corporations like CVS Health.
- The withholding of shares for tax purposes is a common practice when employees become retirement eligible.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a small number of shares being withheld for tax purposes.
- The filing provides transparency to stakeholders regarding executive compensation and share ownership.
Key Dates
| Date | Description |
|---|---|
| 04/03/2018 | Start date for vesting of stock options with an exercise price of $78.05. |
| 04/01/2019 | Start date for vesting of stock options with an exercise price of $62.21. |
| 04/01/2020 | Start date for vesting of stock options with an exercise price of $54.19. |
| 04/01/2021 | Start date for vesting of stock options with an exercise price of $58.34. |
| 04/01/2022 | Start date for vesting of stock options with an exercise price of $74.30. |
| 04/01/2023 | Start date for vesting of stock options with an exercise price of $101.09. |
| 04/01/2024 | Start date for vesting of stock options with an exercise price of $74.31. |
| 11/30/2024 | Date of the reported share transaction where 86 shares were withheld for FICA taxes. |
| 12/03/2024 | Date the Form 4 was signed. |
Keywords
Form 4, CVS Health, James David Clark, stock options, share transaction, FICA taxes, insider trading, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.